Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1885863 | 1.00 | TSHR (0.67) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL6273213 | 0.97 | TSHR (0.62) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL13963394 | 0.93 | TSHR (0.65) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL15293621 | 0.93 | TSHR (0.65) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| Ammonia Solution, Strong SCHEMBL28386014 | 0.90 | TSHR (0.62) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL117529 | 0.90 | TSHR (0.68) | TSHRCYP3A4ALDH1A1TP53TDP1 | |
| SCHEMBL15283502 | 0.89 | TSHR (0.88) | TSHRCYP3A4THRBHPGDSMN1; SMN2 | |
| SCHEMBL7556520 | 0.86 | CYP3A4 (0.76) | TSHRCYP3A4HPGDSMN1; SMN2 | |
| SCHEMBL5600582 | 0.85 | CYP3A4 (0.61) | TSHRCYP3A4ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5602837 | 0.85 | CYP3A4 (0.61) | TSHRCYP3A4ALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3089472-B1 | VIBRATION DAMPING MATERIAL | KAO CORP (JP) | 2018-10-31 | — | — | EP | disclosed |
| EP-2975089-B1 | POLYLACTIC ACID RESIN COMPOSITION | KAO CORP (JP) | 2018-10-17 | — | — | EP | disclosed |
| US-9721555-B2 | Vibration damping material | KAO CORPORATION (JP) | 2017-08-01 | — | — | US | disclosed |
| US-9587130-B2 | Anti-kogation agents | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2017-03-07 | — | — | US | disclosed |
| US-9505913-B2 | Polylactic acid resin composition | KAO CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| EP-3089472-A1 | VIBRATION DAMPING MATERIAL | Kao Corporation (JP) | 2016-11-02 | — | — | EP | disclosed |
| US-20160314776-A1 | VIBRATION DAMPING MATERIAL | KAO CORPORATION (JP) | 2016-10-27 | — | — | US | disclosed |
| EP-2851388-B1 | POLYLACTIC ACID RESIN SHEET FOR THERMAL MOLDING USE | KAO CORP (JP) | 2016-09-21 | — | — | EP | disclosed |
| EP-2975089-A1 | POLYLACTIC ACID RESIN COMPOSITION | Kao Corporation (JP) | 2016-01-20 | — | — | EP | disclosed |
| US-20160002443-A1 | POLYLACTIC ACID RESIN COMPOSITION | TOKAI CHEMICAL INDUSTRIES, LTD. (JP) | 2016-01-07 | — | — | US | disclosed |
| EP-1313802-B1 | PREPARING STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE) | OCCIDENTAL CHEM CO (US) | 2007-06-20 | — | — | EP | disclosed |
| US-6932975-B2 | Cosmetic composition comprising a phosphoric triester and a skin activating component | KAO CORPORATION (JP) | 2005-08-23 | — | — | US | disclosed |
| US-20050123578-A1 | Method of treating skin with a composition comprising a phosphoric triester and a skin activating component | KAO CORPORATION (JP) | 2005-06-09 | — | — | US | disclosed |
| EP-1313802-A2 | PREPARING STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE) | OCCIDENTAL CHEMICAL CORPORATION, Occidental Tower (US) | 2003-05-28 | — | — | EP | disclosed |
| US-20020187166-A1 | COSMETIC COMPOSITION COMPRISING A PHOSPHORIC TRIESTER AND A SKIN ACTIVATING COMPONENT | KAO CORPORATION (JP) | 2002-12-12 | — | — | US | disclosed |
| US-6451904-B1 | DISCOLORATION INHIBITION OF POLYVINYL CHLORIDE WHEN EXPOSED TO IONIZING RADIATION | OCCIDENTAL CHEMICAL CORPORATION | 2002-09-17 | — | — | US | disclosed |
| US-20020055584-A1 | Preparing sterile articles from polymers containing a stabilizer based on a poly (oxyalkylene) | OCCIDENTAL CHEMICAL CORPORATION | 2002-05-09 | — | — | US | disclosed |
| WO-2002017972-A2 | PREPARING STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE) | OCCIDENTAL CHEMICAL CORPORATION (US) | 2002-03-07 | — | — | WO | disclosed |
| US-6348517-B1 | HALOGEN CONTAINING POLYMERS WITH STABILIZERS FOR STERILE ARTICLES | OXY SERVICES, INC. | 2002-02-19 | — | — | US | disclosed |
| EP-0965328-A1 | COSMETIC | Kao Corporation (JP) | 1999-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055584-A1 | Preparing sterile articles from polymers containing a stabilizer based on a poly (oxyalkylene) | SFN, XRCC6, SPOUT1 | TSHR 1248/4885CYP3A4 2197/4885ALDH1A1 3954/4885 |
| US-20050123578-A1 | Method of treating skin with a composition comprising a phosphoric triester and a skin activating component | CUTA, PIM1, PIM2 | TSHR 1920/4885CYP3A4 3561/4885ALDH1A1 3649/4885 |
| US-20020187166-A1 | COSMETIC COMPOSITION COMPRISING A PHOSPHORIC TRIESTER AND A SKIN ACTIVATING COMPONENT | CUTA, PIM1, PIM2 | TSHR 2181/4885CYP3A4 3813/4885ALDH1A1 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.